Zilovertamab vedotin

CAT: 0931-MF-0156286-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0156286-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Target
Apoptosis|||Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related|||Apoptosis
Bioactivity
Zilovertamab vedotin (VLS-101) is a novel antibody-drug conjugate composed of the humanized monoclonal antibody zilovertamab linked to the anti-microtubule cytotoxin monomethyl auristatin E (MMAE) . Upon binding to ROR1 on tumor cells, it is rapidly internalized and directed to lysosomes for cleavage, releasing MMAE and inducing apoptosis in targeted cells. Zilovertamab vedotin has potential applications in cancer research [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
MF-0098991-01Zilovertamab
MF-0050263-01Disitamab vedotin
MF-0100612-01Ladiratuzumab vedotin
MF-0100600-01Ozuriftamab vedotin
MF-0099942-01Sofituzumab vedotin
MF-0099541-01Telisotuzumab vedotin
MF-0100604-01Azintuxizumab vedotin
MF-0100593-01Indusatumab vedotin
MF-0098951-01Brentuximab vedotin
MF-0098779-01Glembatumumab vedotin

Alternative Products

CatalogName
MBS5819107Zilovertamab vedotin
DHF90799Zilovertamab vedotin (ADC)
F1041-5Anti-ROR1 Antibody (Zilovertamab vedotin)
ICH5158V-0.1mgZilovertamab Vedotin Biosimilar - Research Grade
MBS9247025-01Anti-ROR1 Reference Antibody (zilovertamab vedotin)
BIO0878SM-1mgAnti-human ROR1 (Zilovertamab vedotin Biosimilar)
M36698-01Zilovertamab
TRC-V415650-5MGVedotin
HX065016-01Research Grade Zilovertamab
047805ROR1 (zilovertamab) discontinued

Popular Products